Theraptech
-
Companies Commence Therapeutic Protein Development Program
Alloksys Life Sciences, CEVEC Pharmaceuticals and PharmaCell have announced the start of Theraptech, a €2.4 million ($3 million) therapeutic protein development program subsidized under the European Trans Bio Program. The major objective of the pro…
Theraptech | 06 March 2009
